-
A Multicenter Randomized Double-Blind Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in ...
The study will enroll subjects who have completed Study M16-067 or Study M16-065 and have achieved clinical response, defined as ...
Exact
Phase 
-
A Multicenter Randomized Double-Blind Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to ...
The trial will enroll subjects who have had an inadequate response (IR) to prior biologic therapy (bio-IR). The bio-IR population ...
Exact
Phase
-
Study to Investigate the Efficacy and Safety of ABBV-323 in Subjects with Moderate to Severe Ulcerative Colitis who failed prior ...
You are being invited to participate in this study because you have been diagnosed with moderate to severe ulcerative colitis ...Free text
Phase 
-
Profiling and Perturbing the Human Immune System to Understand the Human Immune Network
This study aims to compare IBD patients with healthy controls to obtain a systems-level view of immune system perturbation by ...
Free text
Showing - of trials